Recognized Innovation in Cellular Wellness

The X39® +
Cellergize™ Morning

Recognized as 2025 BioTech Breakthrough
"Stem Cell Innovation Product of the Year"
Selected from thousands of entries across 15+ countries.

The Science, Simply

A different kind of wellness technology

LifeWave's life technology combines proven science with a simple idea — support the body's own ability to live well. X39® uses a patented, proprietary form of phototherapy: low-level light. No drugs, no stimulants, no chemicals entering the body.

Learn the science »

Experience the Benefits

What the technology supports

Supports Exercise Performance

Supports Mental Clarity

Supports Skin Appearance

Supports Energy & Vitality

Supports Faster Recovery From Exercise

No drugs · no stimulants

Join the Community

Choose the way that fits you

Retail Customer

  • Enjoy your favorite products at retail price
Shop Now
POPULAR

Preferred Customer

  • Free to join
  • Wholesale pricing
  • Monthly subscription
  • Free sample after 3 months
Sign Up & Save

Preferred Customer Plus

  • Small annual fee
  • Wholesale pricing
  • Monthly free sample
  • Product credit for sharing
Sign Up & Save

Brand Partner

  • Become the CEO of your own LifeWave business
  • Earn by sharing & building a team
Become a Partner
Fact · Problem · Approach
FactThe less cellular activity you have, the more slowly the body tends to renew.
ProblemResearch suggests cellular activity declines significantly with age — beginning as early as our mid-30s.
The ApproachWith an affordable advance in light technology, you can support your body's own stem cell activity daily — no injections, for about the cost of a coffee a day.
Start Supporting Your Cells
Activate Your Stem Cells
X39® & Cellergize™
The Products

LifeWave X39® Patches + Cellergize™ Morning

X39® supports the flow of energy in the body for improvements in strength, stamina and beyond, by gently stimulating the skin with light. Pair it with Cellergize™ Morning — delicious morning and night drink supplements designed to work in harmony with the patch.

Benefits

  • Low-level light technology supports improved energy flow
  • Supports improved exercise performance
  • Supports improvements in strength and stamina
  • Supports overall health and well-being
  • No drugs or stimulants
  • Patented proprietary form of phototherapy
See It Explained

Hear it from the source

David Schmidt
The Science Behind It

Built on decades of phototherapy research

LifeWave's wearable wellness technology grew out of phototherapy research spanning 30+ years and 200+ patents.
David Schmidt is the inventor of the X39 technology and founder of LifeWave. His experience in business and product development spans over 30 years and includes a formal education in Management Information Systems and Biology at Pace University in Pleasantville, NY. David developed new methods for producing hydrogen and oxygen, designed and prototyped multi-fueled, bladeless-turbine power generation systems, and constructed metal-combustion rocket engines. Globally, David has recently been awarded his 200th patent, with many more being written. More than 70 of those issued patents are in the field of regenerative science and technology. One of his inventions, the Double Helix Conductor, produces a novel blend of electromagnetic and non-electromagnetic fields to improve the speed of wound healing that rivals that of stem-cell injections. It took over 10 years of research and $4.5 million invested, before the X39 technology came to fruition. X39 stands for prototype X39. David Schmidt founded LifeWave over 20 years ago and is committed to the network marketing industry. He has fallen in love with the people and is committed to position every LifeWave Brand Partner for success. Because this technology is the life calling of David Schmidt, the X39 wearable patch is far superior of a product than any other product in the direct sales industry.

Get Started Today

Begin supporting your cells

Have questions?

// GHL: replace with your GHL form; map dropdown to "Interest" + tags.